Related Experiment Videos
[Clinico-morphological characteristics of lymphogranulomatosis in young children]
Insights
This study analyzed lymphogranulomatosis in young children, defining its key clinical and morphological features in infants. It also estimated the 5-year survival rates for patients undergoing current treatment programs.
Area of Science:
- Pediatric Oncology
- Clinical Pathology
- Medical Research
Background:
- Lymphogranulomatosis, a serious childhood disease, requires detailed understanding for effective management.
- Early diagnosis and characterization are crucial for improving outcomes in pediatric patients.
Purpose of the Study:
- To conduct a clinico-morphological analysis of lymphogranulomatosis in children aged 1 to 3 years 11 months.
- To identify distinctive clinical and morphological features of the disease in infants.
- To estimate the 5-year survival rate in patients receiving current treatment.
Main Methods:
- Retrospective analysis of clinical data from 67 pediatric patients with lymphogranulomatosis.
- Morphological examination of tissue samples to identify disease characteristics.
- Survival analysis based on current treatment protocols.
Main Results:
- Defined specific morphological features of lymphogranulomatosis in infants.
- Identified unique clinical presentation traits in the pediatric population.
- Estimated 5-year survival rates for children undergoing contemporary treatment.
Conclusions:
- The study provides critical insights into the clinico-morphological aspects of infant lymphogranulomatosis.
- Understanding these features aids in early diagnosis and tailored treatment strategies.
- The findings contribute to assessing the efficacy of current therapeutic approaches and patient prognosis.
Abstract:
Cases of lymphogranulomatosis underwent a clinico-morphological analysis in 67 children aged 1 year to 3 years 11 months. The morphological features of the process and distinctive traits of the clinical picture of the disease in infants were defined. The 5-year survival in patients undergoing the current treatment programs was estimated.